Abstract
AbstractPhysical activity and several pharmacological approaches individually combat age-associated conditions and extend healthy longevity in model systems. It is tantalizing to extrapolate that combining geroprotector drugs with exercise could extend healthy longevity beyond any individual treatment. However, the current dogma suggests that taking leading geroprotector drugs on the same day as exercise may limit several health benefits. Here, we review leading candidate geroprotector drugs and their interactions with exercise and highlight salient gaps in knowledge that need to be addressed to identify if geroprotector drugs can have a harmonious relationship with exercise.
Funder
American Federation for Aging Research
National Institute on Aging
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Diabetes and Digestive and Kidney Diseases
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Developmental Biology,Plant Science,General Agricultural and Biological Sciences,General Biochemistry, Genetics and Molecular Biology,Physiology,Ecology, Evolution, Behavior and Systematics,Structural Biology,Biotechnology
Reference207 articles.
1. World Health Organization. Global health and aging. In 2011. https://www.nia.nih.gov/sites/default/files/2017-06/global_health_aging.pdf.
2. Burch JB, Augustine AD, Frieden LA, Hadley E, Howcroft TK, Johnson R, et al. Advances in geroscience: impact on healthspan and chronic disease. J Gerontol Ser A Biol Sci Med Sci. 2014;69(SUPPL. 1):1–3.
3. Niccoli T, Partridge L. Ageing as a risk factor for disease. Curr Biol [Internet]. 2012;22(17):R741–52. Available from: https://doi.org/10.1016/j.cub.2012.07.024
4. Partridge L, Deelen J, Slagboom PE. Facing up to the global challenges of ageing. Nature [Internet]. 2018;561(7721):45–56. Available from: https://doi.org/10.1038/s41586-018-0457-8
5. Bloom DE, Cafiero ET, Jané-Llopis E, Abrahams-Gessel S, Bloom LR, Fathima S, et al. The global economic burden of non-communicable diseases. Geneva World Econ Forum. 2010;10(8):910–5.